Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis.
about
Exciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaMolecular responses to hypoxia in tumor cellsGlioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.Modulation of angiogenic and inflammatory response in glioblastoma by hypoxiaTranscriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cellsThe role of chemoattractant receptors in shaping the tumor microenvironment.Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells.Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells.The role of CXC chemokines in the regulation of tumor angiogenesis.The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesisEnhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential.DARC and D6: silent partners in chemokine regulation?Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors.3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model.Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness.Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectivenessInfluence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment.Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells.'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis.Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivoNecrotic cells influence migration and invasion of glioblastoma via NF-κB/AP-1-mediated IL-8 regulation.Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients.Stem cells tropism for malignant gliomas.Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib.Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.Targeting of the innate immunity/inflammation as complementary anti-tumor therapies.Gene polymorphisms: the keys for marker assisted selection and unraveling core regulatory pathways for mastitis resistance.Prognostic markers of astrocytoma: how to predict the unpredictable?Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation.Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer.The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity.
P2860
Q24632791-45011586-47F8-4E6F-9EF0-7FD923B1E40EQ24797310-B17D4128-2EE2-45B1-A21F-9910D01037EBQ31101680-B9226053-37BE-45F4-8A2C-7619872AA162Q33112684-CE788514-C404-4E8A-9E1A-53E702663387Q33470265-7687D9F3-5C2E-43C2-AE9B-2273A1882676Q33698797-0C5426C5-2CC8-40AB-9CE5-C8CC935DE676Q33993124-A014BC6A-5D6A-4657-B3B9-07312650330AQ34174522-D48E9389-A1E5-4384-AC5F-0AE5ACDE201DQ34202118-A1B1FFC6-15A0-4BB5-AD39-0BFC75C70262Q34272896-48378000-5C89-4F32-A273-DD46F02253AEQ34385436-EC4B1C21-F3E7-4A80-A31F-4F40A1D473AEQ34411509-D7AC82CF-3B58-4CC6-9088-7FE16D7556E9Q34540077-1F466888-453C-445F-879D-D74F87305F4BQ34585551-97E52777-320F-4228-9CF9-7E15BD583E53Q34786110-0BDD6CE9-94EF-417A-A7CF-577AA2D6A471Q35563684-1146BECB-FA3C-417D-92F9-F6BDDFD67478Q35745397-15E8CE06-85E1-4647-93F0-FDB2FEF9C372Q35787877-C3009DE2-452B-4381-B70B-C74AE07BB4E6Q35973308-29A2D4D5-89D7-4672-9E59-2FEBDD04E5E5Q36014408-840303CA-7A24-4E4B-A325-46B00AD8228CQ36234132-2FFA51BB-26DB-455A-980A-5D474E7342B8Q36292019-CC184362-6E2C-412B-876B-D349D65646BCQ36368481-2E3C9BDD-20B0-455A-87D8-5287D52F6FFCQ36510818-AA6E5342-0EE8-4A0A-B14D-7E68B067F8B8Q36557180-68CF4FC5-7701-4F8D-BC1A-1D9D40F93AA0Q36796276-345FD358-2F95-4B49-8EF2-4391445FEB22Q36935622-ED54CCBE-A38F-463E-B79D-C445A44C6A48Q37026653-8D1EEA6F-5002-4E16-A7CF-C0510FDAFD5CQ37384020-762F3974-DD88-4347-80EE-32CDE3EEB6D1Q37433709-8BD7A714-7B37-428F-9087-E5C15A04ACC1Q37520432-3EEA4341-1AFF-4966-BCDA-005EB784A348Q37660315-DA83C8C1-9436-45FB-9CF4-E83BE7ECA9E1Q37901025-82DCBF52-4733-47CD-98E6-93FE08919FDCQ37945498-E468EAB8-2F48-408C-857B-7945FF360DE2Q38089921-9F41E2B6-749C-4D18-90A0-454818EB89B9Q38227496-59611F8F-0017-498B-B314-84D8F6B406D2Q38303390-61D325F7-6E83-4396-A6C7-87919D99E5EAQ38342979-94C70054-A4BA-4631-9899-7A183E21190DQ38586188-ECFE12B5-12E5-44FA-B8E3-6BCC359D133AQ38891976-6F24EF9A-77CB-4692-B263-33E97F0659B4
P2860
Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Upregulation of interleukin 8 ...... chemotaxis, and angiogenesis.
@ast
Upregulation of interleukin 8 ...... chemotaxis, and angiogenesis.
@en
type
label
Upregulation of interleukin 8 ...... chemotaxis, and angiogenesis.
@ast
Upregulation of interleukin 8 ...... chemotaxis, and angiogenesis.
@en
prefLabel
Upregulation of interleukin 8 ...... chemotaxis, and angiogenesis.
@ast
Upregulation of interleukin 8 ...... chemotaxis, and angiogenesis.
@en
P2093
P2860
P356
P1476
Upregulation of interleukin 8 ...... chemotaxis, and angiogenesis.
@en
P2093
A C Diserens
I Desbaillets
N Tribolet
P2860
P304
P356
10.1084/JEM.186.8.1201
P407
P577
1997-10-01T00:00:00Z